The Online Investor
Daily M&A
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Mon., Sep. 26, 9:50 PM

Slide #2. CANTEL MEDICAL CORP. EndoscopeReprocessing Business Assets from Vantage Endoscopy, Inc.

Acquiree: EndoscopeReprocessing Business Assets from Vantage Endoscopy, Inc.
Details: CANTEL MEDICAL CORP. (NYSE: CMN), a leading global company dedicated to delivering innovative infection prevention products and services, today announced that the Company has expanded its direct sales operations in Canada by acquiring endoscope reprocessing business assets from its Canadian distributor, Vantage Endoscopy, Inc., a subsidiary of Diploma Canada Holdings Ltd. The endoscope reprocessing business consists of Cantel's Medivators-branded automated endoscope reprocessors, chemistries, consumables and a full sales and service organization.

Cantel Medical is a provider of infection prevention and control products and services in the healthcare market. Co. is engaged in the following operating segments: Endoscopy, which provides medical device reprocessing systems, disinfectants, detergents and other supplies used to disinfect endoscopes; Water Purification and Filtration, which includes water purification equipment and services, filtration and separation products, and disinfectants, sterilization and decontamination products and services; Healthcare Disposables, which includes infection prevention and control healthcare products; and Dialysis, which includes dialysate concentrates and other supplies for renal dialysis.

CMN SEC Filing Email Alerts Service

Open the CMN Page at The Online Investor »

Company Name:  Cantel Medical Corp
Sector:  Medical Instruments & Supplies
Number of ETFs Holding CMN:  45
Total Market Value Held by ETFs:  $228.97M
Total Market Capitalization:  $3.39B
% of Market Cap. Held by ETFs:  6.75%

Open the CMN Page at The Online Investor (in a new window) »

September 26, 2016    9:50 PM Eastern
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Mergers & Acquisitions | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.